<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for SGEN</title>
    <link />
    <description>Headlines for Seattle Genetics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Hodgkin Lymphoma: The Top Secret Strategy Of Seattle Genetics Revealed</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1452561-hodgkin-lymphoma-the-top-secret-strategy-of-seattle-genetics-revealed.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 06:02:00 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics Inc. Presents at UBS Global Healthcare Conference, May-21-2013 11:30 AM</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1451001-seattle-genetics-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-11-30-am.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 15:30:04 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/biotech-companies-see-insider-purchases-ceo-phillip-frost-increases-stake-in-opko-and-felix-baker-buys-acadia-cm247258.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 20 May 2013 11:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Leukemia's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/tackling-cancer-leukemias-biggest-current-upcoming/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>SGEN's Adcetris under FDA Review - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99586/sgens-adcetris-under-fda-review.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 16 May 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435661-seattle-genetics-ceo-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 00:31:12 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by t</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/seattle-genetics-announces-adcetris-brentuximab-ve/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 09:36:36 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics Announces ADCETRIS Supplemental BLA Accepted for Filing by the FDA</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3587263/seattle-genetics-announces-adcetris-supplemental-bla-accepted-for-filing-by-the-f.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 14 May 2013 09:03:35 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics to Present at Upcoming Investor Conferences</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/seattle-genetics-to-present-at-upcoming-investor-c/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 14:20:15 GMT</pubDate>
    </item>
    <item>
      <title>The True Value Of Seattle Genetics</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1417711-the-true-value-of-seattle-genetics.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 04:09:58 GMT</pubDate>
    </item>
    <item>
      <title>Narrower-than-Expected Loss at Seattle Genetics  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98899/narrower-than-expected-loss-at-seattle-genetics.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 09:43:01 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1411801-seattle-genetics-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 20:40:05 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics Reports First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/seattle-genetics-reports-first-quarter-2013-financ/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 17:20:45 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/pharmacyclics-inc-pcyc-todays-most-compelling-stock-buy-cm244319.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 07 May 2013 13:53:41 GMT</pubDate>
    </item>
    <item>
      <title>Three Top Performing Healthcare Stocks to Watch</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/05/3562518/three-top-performing-healthcare-stocks-to-watch.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 06 May 2013 15:53:30 GMT</pubDate>
    </item>
    <item>
      <title>Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/polycyclics-inc-pcyc-todays-most-compelling-stock-pick-cm241222.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 26 Apr 2013 15:20:21 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-30.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 19 Apr 2013 14:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2013 Financial Resu</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/18/seattle-genetics-to-host-conference-call-and-webca/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 18 Apr 2013 09:36:31 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Non-Hodgkin Lymphoma's Biggest Current &amp; Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/17/tackling-cancer-non-hodgkin-lymphomas-biggest-curr/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 17 Apr 2013 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>There Is A Lot To Like About Celldex Therapeutics</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1346741-there-is-a-lot-to-like-about-celldex-therapeutics.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 06:11:39 GMT</pubDate>
    </item>
  </channel>
</rss>
